1. Means, R. Pure red cell aplasia. Hematology Am Soc Hematol Educ Program. 2016;2016:51-56.
Google Scholar | Crossref | Medline2. Balasubramanian, SK, Sadaps, M, Thoat, S, et al. Rational management approach to pure red cell aplasia. Haematologica. 2018;103(2):221-230.
Google Scholar | Crossref | Medline3. Alabbas, F, Elyamany, G, Alsharif, O, Hershfield, M, Meyts, I. Childhood hodgkin lymphoma: think DADA2. J Clin Immunol. 2019;39(1):26-29.
Google Scholar | Crossref | Medline4. Hashem, H, Egler, R, Dalal, J. Refractory pure red cell aplasia manifesting as deficiency of adenosine deaminase 2. J Pediatr Hematol Oncol. 2017;39(5):e293-e296.
Google Scholar | Crossref | Medline5. Zhou, Q, Yang, D, Ombrello, AK, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370(10):911-920.
Google Scholar | Crossref | Medline6. Van Montfrans, J, Zavialov, A, Zhou, Q. Mutant ADA2 in vasculopathies. N Engl J Med. 2014;371(5):477-478.
Google Scholar7. Ben-Ami, T, Revel-Vilk, S, Brooks, R, et al. Extending the clinical phenotype of adenosine deaminase 2 deficiency. J Pediatr. 2016;177:316-320.
Google Scholar | Crossref | Medline8. Sasa, G, Elghetany, M, Bergstrom, K, et al. Adenosine deaminase 2 deficiency as a cause of pure red cell aplasia mimicking Diamond Blackfan anemia. Blood. 2015;126 (23):3615-3615.
Google Scholar | Crossref9. Ersoy, E, Bayram, C, Gökçe, M, Ünal, S, Ozdemir, NN. ADA 2 enzyme deficiency manifesting as pure red cell aplasia. EHA Library. Ozdemir G. 2018;216110:PB1834.
Google Scholar10. Nanthapisal, S, Murphy, C, Omoyinmi, E, et al. Deficiency of adenosine deaminase type 2: a description of phenotype and genotype in fifteen cases. Arthritis Rheumatol. 2016;68(9):2314-2322.
Google Scholar | Crossref | Medline11. Michniacki, TF, Hannibal, M, Ross, CW, et al. Hematologic manifestations of Deficiency of Adenosine Deaminase 2 (DADA2) and response to tumor necrosis factor inhibition in dada2-associated bone marrow failure. J Clin Immunol. 2018;38(2):166-173.
Google Scholar | Crossref | Medline12. Ekinci, RMK, Balci, S, Bisgin, A, et al. A homozygote novel L451W mutation in CECR1 gene causes deficiency of adenosine deaminase 2 in a pediatric patient representing with chronic lymphoproliferation and cytopenia. Pediatr Hematol Oncol. 2019;36(6):376-381.
Google Scholar | Crossref | Medline13. Lee, PY, Kellner, ES, Huang, Y, et al. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2). J Allergy Clin Immunol. 2020;145(6):1664-1672.e10.
Google Scholar | Crossref14. Van Eyck, L, Hershfield, M, Pombal, D, et al. Hematopoietic stem cell transplantation rescues the immunologic phenotype and prevents vasculopathy in patients with adenosine deaminase 2 deficiency. J Allergy Clin Immunol. 2015;135(1):283-287.e5.
Google Scholar | Crossref | Medline15. Trotta, L, Martelius, T, Siitonen, T, et al. ADA2 deficiency: clonal lymphoproliferation in a subset of patients. J Allergy Clin Immunol. 2018;141(4):1534-1537.e8.
Google Scholar | Crossref | Medline16. Sundin, M, Marits, P, Nierkens, S, Kolios, AGA, Nilsson, J. “Immune” thrombocytopenia as key feature of a novel ADA2 deficiency variant: implication on differential diagnostics of ITP in children. J Pediatr Hematol Oncol. 2019;41(2):155-157.
Google Scholar | Crossref | Medline17. Fellmann, F, Angelini, F, Wassenberg, J, et al. IL-17 receptor A and adenosine deaminase 2 deficiency in siblings with recurrent infections and chronic inflammation. J Allergy Clin Immunol. 2016;137(4):1189-1196.e2.
Google Scholar | Crossref | Medline18. Cipe, FE, Aydogmus, C, Serwas, NK, Keskindemirci, G, Boztuğ, K. Novel Mutation in CECR1 leads to deficiency of ADA2 with associated neutropenia. J Clin Immunol. 2018;38(3):273-277.
Google Scholar | Crossref | Medline19. Hsu, A, West, R, Calvo, K, et al. Adenosine deaminase type 2 deficiency masquerading as GATA2 deficiency: successful hematopoietic stem cell transplantation. J Allergy Clin Immunol. 2016;138(2):628-630.e2.
Google Scholar | Crossref20. Claassen, D, Boals, M, Bowling, K, et al. Complexities of genetic diagnosis illustrated by an atypical case of congenital hypoplastic anemia. Cold Spring Harb Mol Case Stud. 2018;4(6):2-7.
Google Scholar | Crossref21. Ghurye, R, Sundaram, K, Smith, F, et al. Novel ADA2 mutation presenting with neutropenia, lymphopenia and bone marrow failure in patients with deficiency in adenosine deaminase 2 (DADA2). Br J Haematol. 2019;186(3):e60–e64.
Google Scholar | Medline22. Rama, M, Dulfos, C, Melki, I, et al. A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experience. Eur J Hum Genet. 2018;26(7):960-971.
Google Scholar | Crossref | Medline23. Alsultan, A, Basher, E, Alqanatish, J, Mohammed, R, Alfadhel, M. Deficiency of ADA2 mimicking autoimmune lymphoproliferative syndrome in the absence of livedo reticularis and vasculitis. Pediatr Blood Cancer. 2018;65(4). doi:10.1002/pbc.26912.
Google Scholar | Crossref | Medline24. Barzaghi, F, Minniti, F, Mauro, M, et al. ALPS-like phenotype caused by ADA2 deficiency rescued by allogeneic hematopoietic stem cell transplantation. Front Immunol. 2019;9:2767.
Google Scholar | Crossref | Medline25. Batu, ED, Karadag, O, Taskiran, EZ, et al. A case series of adenosine deaminase 2-deficient patients emphasizing treatment and genotype-phenotype correlations. J Rheumatol. 2015;2:2-4.
Google Scholar26. Uettwiller, F, Sarrabay, G, Rodero, MP, et al. ADA2 deficiency: case report of a new phenotype and novel mutation in two sisters. RMD Open 2016;2(1):1-5.
Google Scholar | Crossref27. Sahin, S, Adrovic, A, Barrut, K, et al. Clinical, imaging and genotypical features of three deceased and five surviving cases with ADA2 deficiency. Rheumatol Int. 2018;38(1):129-136.
Google Scholar | Crossref | Medline28. Schepp, J, Proietti, M, Frede, N, et al. Screening of 181 patients with antibody deficiency for deficiency of adenosine deaminase 2 sheds new light on the disease in adulthood. Arthritis Rheumatol. 2017;69(8):1689-1700.
Google Scholar | Crossref | Medline29. Özen, S, Batu, ED, Taşkıran, EZ, et al. A monogenic disease with a variety of phenotypes: deficiency of adenosine deaminase 2. J Rheumatol. 2020;47(1):117-125.
Google Scholar | Crossref | Medline30. Ulirsch, JC, Verboon, JM, Kazerounian, S, et al. The genetic landscape of Diamond-Blackfan anemia. Am J Hum Genet. 2018;103(6):930-947.
Google Scholar | Crossref | Medline31. Swerdlow, SH, Campo, E, Pileri, SA, et al. WHO classification of tumours of the haematopoietic and lymphoid tissues review series the updated who classification of hematological malignancies The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375-90
Google Scholar | Crossref | Medline32. Thomas, RK, Re, D, Wolf, J, Diehl, V. Part I: Hodgkin’s lymphoma—molecular biology of hodgkin and reed-sternberg cells. Lancet Oncol. 2004;5(1):11-18.
Google Scholar | Crossref | Medline33. Caorsi, R, Penco, F, Grossi, A, et al. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study. Ann Rheum Dis. 2017;76(10):1648-1656.
Google Scholar | Crossref | Medline34. Hashem, H, Kumar, AR, Müller, I, et al. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2. Blood. 2017;130(24):2682-2688.
Google Scholar | Crossref | Medline